Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -45,318 | -1,948 | -3,620 | -4,268 | N/A |
| Depreciation Amortization | 10 | 5 | 2 | 2 | N/A |
| Accounts receivable | N/A | N/A | -161 | 7 | N/A |
| Accounts payable and accrued liabilities | 3,755 | 474 | -1,721 | 1,021 | N/A |
| Other Working Capital | 4,672 | 466 | -1,882 | 1,028 | N/A |
| Other Operating Activity | 31,914 | -474 | 1,932 | 76 | 0 |
| Operating Cash Flow | $-4,966 | $-1,477 | $-5,450 | $-2,134 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 1,402 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $1,392 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,031 | 432 | N/A | 890 | N/A |
| Debt Repayment | -3,561 | N/A | -1,100 | N/A | N/A |
| Common Stock Issued | 75,000 | 3,691 | 13,103 | 2,224 | N/A |
| Other Financing Activity | -5,426 | 112 | 0 | 118 | 0 |
| Financing Cash Flow | $69,044 | $4,235 | $12,003 | $3,232 | $N/A |
| Exchange Rate Effect | 122 | 15 | N/A | N/A | N/A |
| Beginning Cash Position | 3,328 | 554 | 1,104 | 6 | N/A |
| End Cash Position | 68,920 | 3,328 | 7,657 | 1,104 | N/A |
| Net Cash Flow | $65,593 | $2,774 | $6,553 | $1,098 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,966 | -1,477 | -5,450 | -2,134 | N/A |
| Capital Expenditure | -11 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -4,976 | -1,477 | -5,450 | -2,134 | 0 |